ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Rebif 8.8 und 22, Injektionslösung in Fertigspritzen - 6 + 6 Kombipackung(en)
54810060 Merck (Schweiz) AG
Rebif 8.8 und 22, Injektionslösung in Fertigspritzen23.12.1998
  10.10.2008
Interferon Beta-1a (L03AB07)20.12.2006
WHO-DDD 
01.99.6 + 6 Kombipackung(en)
01.99. 
B  
Yes 
IPCI
599.44No
    
10 %668.35
7680548100603Biotechnologika
4062417 
Composition
I) 8.8 mcg/0.2 ml: interferonum beta-1a ADNr 8.8 µg corresp. 2.4 Mio U.I., alcohol benzylicus 1.0 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.2 ml corresp. natrium 0.01 mg. II) 22 mcg/0.5 ml: interferonum beta-1a ADNr 22 µg corresp. 6 Mio U.I., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.03 mg.
Packungsbestandteile
I
 
Injection solution in prefilled syringe 
  
 
Active AgentDose
Interferonum Beta-1a Adnr8.8µg / 0.2ml
BAG: Active AgentDose
Interferonum Beta-1a Adnr22 mcg
 
Inactive agentsDose
Acetic Acid 
Alcohol Benzylicus1mg / 0.2ml
Mannitol 
Methionine 
Sodium Acetate Trihydrate 
Sodium Hydroxide 
Poloxamer188
 
II
 
Injection solution in prefilled syringe 
  
 
Active AgentDose
Interferonum Beta-1a Adnr22µg / 0.5ml
BAG: Active AgentDose
Interferonum Beta-1a Adnr22 mcg
 
Inactive agentsDose
Acetic Acid 
Alcohol Benzylicus2.5mg / 0.5ml
Mannitol 
Methionine 
Sodium Acetate Trihydrate 
Sodium Hydroxide 
Poloxamer188
 
Source
Data was imported : 04.05.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home